These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33707941)

  • 1. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
    Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N
    Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality - The STATUETTE Cohort Study.
    Damkjær M; Suppli Ulrik C; Godtfredsen N; Håkansson KEJ
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2397-2406. PubMed ID: 34465987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.
    Smith MC; Ashdown HF; Sheppard JP; Butler CC; Bankhead C
    BMJ Open; 2021 Dec; 11(12):e050757. PubMed ID: 34876426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and risk of COPD exacerbation requiring hospitalization.
    Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
    Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
    Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
    Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
    Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
    Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.
    Ingebrigtsen TS; Marott JL; Nordestgaard BG; Lange P; Hallas J; Vestbo J
    Thorax; 2015 Jan; 70(1):33-40. PubMed ID: 25349333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
    Daniels K; Lanes S; Tave A; Pollack MF; Mannino DM; Criner G; Neikirk A; Rhodes K; Feigler N; Nordon C
    Int J Chron Obstruct Pulmon Dis; 2024; 19():225-241. PubMed ID: 38259591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.
    Huang YJ; Kao S; Kao LT; Chian CF; Chung CH; Chien WC; Wang KY
    Int J Chron Obstruct Pulmon Dis; 2021; 16():591-602. PubMed ID: 33716501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.
    Sheng X; Murphy MJ; MacDonald TM; Schembri S; Simpson W; Winter J; Winter JH; Wei L
    Clin Ther; 2012 Feb; 34(2):374-84. PubMed ID: 22244052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
    Sun SH; Chang CH; Zhan ZW; Chang WH; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2721-2733. PubMed ID: 34621122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study.
    Vanoverschelde A; Van Hoey C; Buyle F; Den Blauwen N; Depuydt P; Van Braeckel E; Lahousse L
    BMC Pulm Med; 2023 Apr; 23(1):138. PubMed ID: 37098509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.
    Schmidt SA; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Sørensen HT; Christiansen CF
    BMJ Open; 2014 Dec; 4(12):e006720. PubMed ID: 25526796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use is associated with reduced mortality in COPD.
    Søyseth V; Brekke PH; Smith P; Omland T
    Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
    Howard ML; Vincent AH
    Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.
    Lei YF; Lin HC; Lin HL; Uang YS; Cheng HW; Wang LH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2573-2581. PubMed ID: 33116474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients.
    Løkke A; Hilberg O; Lange P; Ibsen R; Stratelis G; de Fine Licht S; Lykkegaard J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():569-578. PubMed ID: 35321533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study.
    Raymakers A; Sin DD; Sadatsafavi M; FitzGerald JM; Marra CA; Lynd LD
    Respir Res; 2020 May; 21(1):118. PubMed ID: 32429927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.
    Hunter LC; Lee RJ; Butcher I; Weir CJ; Fischbacher CM; McAllister D; Wild SH; Hewitt N; Hardie RM
    BMJ Open; 2016 Jan; 6(1):e009121. PubMed ID: 26801463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.